Critical Care After Surgery for Congenital Cardiac Disease

Pediatric Critical Care

Volumn , Issue , 2011, Pages 401-440

  Rotta, Alexandre T ^a,b   Laussen, Peter C ^c,d,e   Wessel, David L ^f,g,h  

^a RILEY HOSPITAL FOR CHILDREN   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Division Cardiovascular Critical Care   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f Center for Hospital Based Specialties   (United States)

^g CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^h GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884452749     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-07307-3.10031-X     Document Type: Chapter

References (211)

1. Heron M., Sutton P.D., Xu J., et al. Annual summary of vital statistics 2007. Pediatrics 2010, 125:4-15.
2. Friedman W.F. The intrinsic physiologic properties of the developing heart. Prog Cardiovasc Dis 1972, 15:87-111.
3. Romero T.E., Friedman W.F. Limited left ventricular response to volume overload in the neonatal period: a comparative study with the adult animal. Pediatr Res 1979, 13:910-915.
4. Mills A.N., Haworth S.G. Greater permeability of the neonatal lung. Postnatal changes in surface charge and biochemistry of porcine pulmonary capillary endothelium. J Thorac Cardiovasc Surg 1991, 101:909-916.
5. Hanley F.L., Heinemann M.K., Jonas R.A., et al. Repair of truncus arteriosus in the neonate. J Thorac Cardiovasc Surg 1993, 105:1047-1056.
6. McCrindle B.W., Tchervenkov C.I., Konstantinov I.E., et al. Risk factors associated with mortality and interventions in 472 neonates with interrupted aortic arch: a Congenital Heart Surgeons Society study. J Thorac Cardiovasc Surg 2005, 129:343-350.
7. Planche C., Serraf A., Comas J.V., et al. Anatomic repair of transposition of great arteries with ventricular septal defect and aortic arch obstruction. One-stage versus two-stage procedure. J Thorac Cardiovasc Surg 1993, 105:925-933.
8. Gladman G., McCrindle B.W., Williams W.G., et al. The modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot's tetralogy in the current era. J Thorac Cardiovasc Surg 1997, 114:25-30.
9. Fisher D.J., Heymann M.A., Rudolph A.M. Fetal myocardial oxygen and carbohydrate consumption during acutely induced hypoxemia. Am J Physiol 1982, 242:H657-H661.
10. Clapp S., Perry B.L., Farooki Z.Q., et al. Down's syndrome, complete atrioventricular canal, and pulmonary vascular obstructive disease. J Thorac Cardiovasc Surg 1990, 100:115-121.
11. Greenwood R.D. Cardiovascular malformations associated with extracardiac anomalies and malformation syndromes. Clin Pediatr 1984, 23:145.
12. Lister G., Hellenbrand W.E., Kleinman C.S., et al. Physiologic effects of increasing hemoglobin concentration in left-to-right shunting in infants with ventricular septal defects. N Engl J Med 1982, 306:502.
13. Sanders S. Echocardiography and related techniques in the diagnosis of congenital heart defects. Echocardiography 1984, 1:185.
14. Freed M.D., Miettinen O.S., Nadas A.S. Oximetric detection of intracardiac left-to-right shunts. Br Heart J 1979, 42:690-694.
15. Rabinovitch M. Pulmonary hypertension. Moss' heart diseases in infants, children and adolescents 1983, Williams & Wilkins, Baltimore, MD. F.H. Adams, G.C. Emmanouilides (Eds.).
16. Fellows K.E., Keane J.F., Freed M.D. Angled views in cineangiography of congenital heart disease. Radiology 1977, 56:485.
17. Geva T. Introduction: magnetic resonance imaging. Pediatr Cardiol 2000, 21:3-4.
18. Chung T. Assessment of cardiovascular anatomy in patients with congenital heart disease by magnetic resonance imaging. Pediatr Cardiol 2000, 21:18-26.
19. Freed M.A., Heyman M.A., Lewis A.B. Prostaglandin E1 in infants with ductus arteriosus-dependent congenital heart disease. Circulation 1981, 64:889.
20. Yokota M., Muraoka R., Aoshima M., et al. Modified Blalock-Taussig shunt following long-term administration of prostaglandin E1 for ductus-dependent neonates with cyanotic congenital heart disease. J Thorac Cardiovasc Surg 1985, 90:399-403.
21. Lewis A.B., Freed M.A., Heymann M.A. Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 1981, 64:893.
22. Donahoo J.S., Roland J.M., Ken J. Prostaglandin E1 as an adjunct to emergency cardiac operation in neonates. J Thorac Cardiovasc Surg 1981, 81:227.
23. Moler F.W., Khan A.S., Meliones J.N., et al. Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience. Crit Care Med 1992, 20:1406-1413.
24. Jonas R.A., Lang P., Mayer J.E., et al. The importance of prostaglandin E1 in resuscitation of the neonate with critical aortic stenosis. J Thorac Cardiovasc Surg 1985, 89:314.
25. Jonas R.A., Hansen D.D., Cook N., et al. Anatomical subtype and survival after reconstructive surgery for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 1994, 107:1121-1127.
26. Lang P., Chipman C.W., Siden M. Early assessment of hemodynamic status after repair of tetralogy of Fallot: a comparison of 24 hour and one year postoperative data in 98 patients. Am J Cardiol 1982, 58:795-799.
27. Wernovsky G., Wypij D., Jonas R.A., et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995, 92:2226-2235.
28. Cullen S., Shore D., Redington A. Characterization of right ventricular diastolic performance after complete repair of tetralogy of Fallot. Restrictive physiology predicts slow postoperative recovery. Circulation 1995, 91:1782-1789.
29. Redington A.N., Penny D., Rigby M.L. Antegrade diastolic pulmonary arterial flow as a marker of right ventricular restriction after complete repair of pulmonary atresia with intact ventricular septum and critical pulmonary valve stenosis. Cardiol Young 1992, 2:382-386.
30. Bridges N.D., Mayer J.E., Lock J.E., et al. Effect of baffle fenestration on outcome of the modified Fontan operation. Circulation 1992, 86:1762-1769.
31. Lemler M.S., Scott W.A., Leonard S.R., et al. Fenestration improves clinical outcome of the Fontan procedure: a prospective, randomized study. Circulation 2002, 105:207-212.
32. Bohn D.J., Poirer C.S., Demonds J.F. Efficacy of dopamine, dobutamine, and epinephrine during emergence from cardiopulmonary bypass in children. Crit Care Med 1980, 8:367-373.
33. Wessel D.L. Managing low cardiac output syndrome after congenital heart surgery. Crit Care Med 2001, 29(Suppl 10):S220-S230.
34. Rosenzweig E.B., Starc T.J., Chen J.M., et al. Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 1999, 100:II182-II186.
35. Scheurer M.A., Bradley S.M., Atz A.M. Vasopressin to attenuate pulmonary hypertension and improve systemic blood pressure after correction of obstructed total anomalous pulmonary venous return. J Thorac Cardiovasc Surg 2005, 129:464-466.
36. Caspi J., Coles J.G., Benson L.N., et al. Age-related response to epinephrine-induced myocardial stress. A functional and ultrastructural study. Circulation 1991, 84(suppl III):III-394-III-399.
37. Caspi J., Coles J.G., Benson L.N., et al. Effects of high plasma epinephrine and Ca2+ concentrations on neonatal myocardial function after ischemia. J Thorac Cardiovasc Surg 1993, 105:59-67.
38. Bailey J.M., Miller B.E., Lu W., et al. The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology 1999, 90:1012-1018.
39. Chang A.C., Atz A.M., Wernovsky G., et al. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 1995, 23:1907-1914.
40. Hoffman T.M., Wernovsky G., Atz A.M., et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003, 107:996-1002.
41. Mainwaring R., Lamberti J., Nelson J., et al. Effects of tri-iodothyronine supplementation following modified Fontan procedure. Cardiol Young 1997, 7:194-200.
42. Bettendorf M., Schmidt K.G., Grulich-Henn J., et al. Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 2000, 356:529-534.
43. Chowdhury D., Parnell V.A., Ojamaa K., et al. Usefulness of triiodothyronine (T3) treatment after surgery for complex congenital heart disease in infants and children. Am J Cardiol 1999, 84:1107-1109. A10.
44. Dimmick S., Badawi N., Randell T. Thyroid hormone supplementation for the prevention of morbidity and mortality in infants undergoing cardiac surgery. Cochrane Database Syst Rev 2004, CD004220.
45. Colucci W.S., Elkayam U., Horton D.P., et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 2000, 343:246-253. [published erratum appears in N Engl J Med 343:1504, 2000].
46. Yancy C.W., Saltzberg M.T., Berkowitz R.L., et al. Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial). Am J Cardiol 2004, 94:595-601.
47. Turanlahti M., Boldt T., Palkama T., et al. Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery. Pediatr Crit Care Med 2004, 5:457-462.
48. Janousek J., Vojtovic P., Hucin B., et al. Resynchronization pacing is a useful adjunct to the management of acute heart failure after surgery for congenital heart defects. Am J Cardiol 2001, 88:145-152.
49. Heath D., Edwards J.E. The pathology of hypertensive pulmonary vascular disease: a description of six grades of structural changes in the pulmonary arteries with special attention to congenital cardiac septal defects. Circulation 1958, 18:533-547.
50. Wessel D.L. Current and future strategies in the treatment of childhood pulmonary hypertension. Prog Pediatr Cardiol 2001, 12:289.
51. Drummond W.H., Gregory G.A., Heymann M.A., et al. The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension. J Pediatr 1981, 98:603-611.
52. Barst R.J., Rubin L.J., Long W.A., et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 1996, 334:296-302.
53. Rosenzweig E.B., Kerstein D., Barst R.J. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation 1999, 99:1858-1865.
54. Zobel G., Dacar D., Rodl S., et al. Inhaled nitric oxide versus inhaled prostacyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets. Pediatr Res 1995, 38:198-204.
55. Petrossian E., Parry A.J., Reddy V.M., et al. Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow. J Thorac Cardiovasc Surg 1999, 117:314-323.
56. Frostell C.G., Fratacci M.D., Wain J.C., et al. Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991, 83:2038-2047.
57. Ignarro L.J., Buga G.M., Wood K.S., et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987, 84:9265-9269.
58. Atz A.M., Wessel D.L. Inhaled nitric oxide in the neonate with cardiac disease. Semin Perinatol 1997, 21:441-455.
59. Journois D., Pouard P., Mauriat P., et al. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 1994, 107:1129-1135.
60. Goldman A.P., Delius R.E., Deanfield J.E., et al. Pharmacological control of pulmonary blood flow with inhaled nitric oxide after the fenestrated Fontan operation. Circulation 1996, 94(Suppl 9):II44-II48.
61. Miller O.I., Tang S.F., Keech A., et al. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet 2000, 356:1464-1469.
62. Adatia I., Atz A.M., Wessel D.L. Inhaled nitric oxide does not improve systemic oxygenation after bidirectional superior cavopulmonary anastomosis. J Thorac Cardiovasc Surg 2005, 129:217-219.
63. Adatia I., Atz A.M., Jonas R.A., et al. Diagnostic use of inhaled nitric oxide after neonatal cardiac operations. J Thorac Cardiovasc Surg 1996, 112:1403-1405.
64. Atz A.M., Wessel D.L. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 1999, 91:307-310.
65. Extracorporeal Life Support Organization ECLS registry report: international summary 2009, Extracorporeal Life Support Organization, Ann Arbor, MI.
66. Chaturvedi R.R., Macrae D., Brown K.L., et al. Cardiac ECMO for biventricular hearts after paediatric open heart surgery. Heart 2004, 90:545-551.
67. Del Nido P.J., Armitage J.M., Fricker F.J., et al. Extracorporeal membrane oxygenation support as a bridge to pediatric heart transplantation. Circulation 1994, 90(5 pt 2):II66-II69.
68. Ibrahim A.E., Duncan B.W., Blume E.D., et al. Long-term follow-up of pediatric cardiac patients requiring mechanical circulatory support. Ann Thorac Surg 2000, 69:186-192.
69. Slonim A.D., Patel K.M., Ruttimann U.E., et al. Cardiopulmonary resuscitation in pediatric intensive care units. Crit Care Med 1997, 25:1951-1955.
70. Schindler M.B., Bohn D., Cox P.N., et al. Outcome of out-of-hospital cardiac or respiratory arrest in children. N Engl J Med 1996, 335:1473-1479.
71. Chen Y.S., Chao A., Yu H.Y., et al. Analysis and results of prolonged resuscitation in cardiac arrest patients rescued by extracorporeal membrane oxygenation. J Am Coll Cardiol 2003, 41:197-203.
72. Nadkarni V., Larkin G., Peberdy M., et al. First documented rhythm and clinical outcome from in-hospital cardiac arrest among children and adults. JAMA 2006, 295:50-57.
73. Lopez-Herce J., Garcia C., Dominguez P., et al. Characteristics and outcome of cardiorespiratory arrest in children. Resuscitation 2004, 63:311-320.
74. Thiagarajan R.R., Laussen P.C., Rycus P.T., et al. Extracorporeal membrane oxygenation to aid cardiopulmonary resuscitation in infants and children. Circulation 2007, 116:1693-1700.
75. Booth K.L., Roth S.J., Perry S.B., et al. Cardiac catheterization of patients supported by extracorporeal membrane oxygenation. J Am Coll Cardiol 2002, 40:1681-1686.
76. Jaggers J.J., Forbess J.M., Shah A.S., et al. Extracorporeal membrane oxygenation for infant postcardiotomy support: significance of shunt management. Ann Thorac Surg 2000, 69:1476-1483.
77. Booth K.L., Roth S.J., Thiagarajan R.R., et al. Extracorporeal membrane oxygenation support of the Fontan and bidirectional Glenn circulations. Ann Thorac Surg 2004, 77:1341-1348.
78. Wessel D.L., Adatia I., Giglia T.M., et al. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993, 88:2128-2138.
79. Burch M., Lum L., Elliott M., et al. Influence of cardiopulmonary bypass on water balance hormones in children. Br Heart J 1992, 68:309-312.
80. Ationu A., Singer D.R., Smith A., et al. Studies of cardiopulmonary bypass in children: implications for the regulation of brain natriuretic peptide. Cardiovasc Res 1993, 27:1538-1541.
81. Carmichael T.B., Walsh E.P., Roth S.J. Anticipatory use of venoarterial extracorporeal membrane oxygenation for a high-risk interventional cardiac procedure. Respir Care 2002, 47:1002-1006.
82. Jenkins J., Lynn A., Edmonds J., et al. Effects of mechanical ventilation on cardiopulmonary function in children after open-heart surgery. Crit Care Med 1985, 13:77-80.
83. Robotham J.L., Lixfeld W., Holland L., et al. The effects of positive end-expiratory pressure on right and left ventricular performance. Am Rev Respir Dis 1980, 121:677-683.
84. Pinsky M.R., Summer W.R., Wise R.A., et al. Augmentation of cardiac function by elevation of intrathoracic pressure. J Appl Physiol 1983, 54:950-955.
85. Mittnacht A.J., Hollinger I. Fast-tracking in pediatric cardiac surgery: the current standing. Ann Card Anaesth 2010, 13:92-101.
86. Vricella L.A., Dearani J.A., Gundry S.R., et al. Ultra fast track in elective congenital cardiac surgery. Ann Thorac Surg 2000, 69:865-871.
87. Newburger J.W., Jonas R.A., Wernovsky G., et al. Perioperative neurologic effects of hypothermic arrest during infant heart surgery. The Boston Circulatory Arrest Study. N Engl J Med 1993, 329:1057-1064.
88. Reddy V.M., McElhinney D.B., Sagrado T., et al. Results of 102 cases of complete repair of congenital heart defects in patients weighing 700 to 2500 grams. J Thorac Cardiovasc Surg 1999, 117:324-331.
89. Elliott M. Modified ultrafiltration and open heart surgery in children. Paediatr Anaesth 1999, 9:1-5.
90. Berenholtz S.M., Pronovost P.J., Lipsett P.A., et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004, 32:2014.
91. Falcao G., Ulate K., Kouzekanani K., et al. Impact of postoperative hyperglycemia followingsurgical repair of congenital cardiac defects. Pediatr Cardiol 2008, 29:628-636.
92. Yates A.R., Dyke P.C., Taeed R., et al. Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient. Pediatr Crit Care Med 2006, 7:351-355.
93. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345:1359-1367.
94. Vlasselaers D., Milants I., Desmet L., et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomized controlled study. Lancet 2009 Feb 14, 373:547-556.
95. Ulate K.P., Lima Falcao G.C., Bielefeld M.R., et al. Strict glycemic targets need not be so strict: a more permissive glycemic range for critically ill children. Pediatrics 2008 Oct, 122(4):e898-e904.
96. Tabbutt S., Ramamoorthy C., Montenegro L.M., et al. Impact of inspired gas mixtures on preoperative infants with hypoplastic left heart syndrome during controlled ventilation. Circulation 2001, 104(12 suppl 1):I159-I164.
97. Ramamoorthy C., Tabbutt S., Kurth C.D., et al. Effects of inspired hypoxic and hypercapnic gas mixtures on cerebral oxygen saturation in neonates with univentricular heart defects. Anesthesiology 2002, 96:283-288.
98. Atz A.M., Feinstein J.A., Jonas R.A., et al. Preoperative management of pulmonary venous hypertension in hypoplastic left heart syndrome with restrictive atrial septal defect. Am J Cardiol 1999, 83:1224-1228.
99. Vlahos A.P., Lock J.E., McElhinney D.B., et al. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: outcome after neonatal transcatheter atrial septostomy. Circulation 2004, 109:2326-2330.
100. Chang A.C., Hanley F.L., Wernovsky G., et al. Early bidirectional cavopulmonary shunt in young infants: postoperative course and early results. Circulation 1993, 88(5 pt 2):II149-II158.
101. Fontan F., Baudet E. Surgical repair of tricuspid atresia. Thorax 1971, 26:240.
102. Castaneda A.R. From Glenn to Fontan. A continuing evolution. Circulation 1992, 86:II80-II84.
103. Fontan F., Kirklin J.W., Fernandez G., et al. Outcome after a "perfect" Fontan operation. Circulation 1990, 81:1520-1536.
104. Gentles T.L., Mayer J.E., Gauvreau K., et al. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg 1997, 114:376-391.
105. Gentles T.L., Gauvreau K., Mayer J.E., et al. Functional outcome after the Fontan operation: factors influencing late morbidity. J Thorac Cardiovasc Surg 1997, 114:392-403.
106. Penny D.J., Redington A.N. Doppler echocardiographic evaluation of pulmonary blood flow after the Fontan operation: the role of the lungs. Br Heart J 1991, 66:372-374.
107. Redington A.N., Penny D., Shinebourne E.A. Pulmonary blood flow after total cavopulmonary shunt. Br Heart J 1991, 65:213-217.
108. Meliones J.N., Bove E.L., Dekeon M.K., et al. High-frequency jet ventilation improves cardiac function after the Fontan procedure. Circulation 1991, 84:III364-III368.
109. Shekerdemian L.S., Bush A., Shore D.F., et al. Cardiopulmonary interactions after Fontan operations: augmentation of cardiac output using negative pressure ventilation. Circulation 1997, 96:3934-3942.
110. Fishberger S.B., Wernovsky G., Gentles T.L., et al. Factors that influence the development of atrial flutter after the Fontan operation. J Thorac Cardiovasc Surg 1997, 113:80-86.
111. Karl T.R., Sano S., Pornviliwan S., et al. Tetralogy of Fallot: favorable outcome of nonneonatal transatrial, transpulmonary repair. Ann Thorac Surg 1992, 54:903-907.
112. Pigula F.A., Khalil P.N., Mayer J.E., et al. Repair of tetralogy of Fallot in neonates and young infants. Circulation 1999, 100(19 suppl):II157-II161.
113. Castaneda A.R., Freed M.D., Williams R.G. Repair of tetralogy of Fallot in infancy. J Thorac Cardiovasc Surg 1977, 74:372.
114. Reference deleted in proofs.
115. Dabizzi R.P., Capriolo G., Aiazzi L. Distribution and anomalies of coronary arteries in tetralogy of Fallot. Circulation 1980, 61:95.
116. Shabbo F.P., Wain W.H., Ross D.N. Right ventricular outflow reconstruction with aortic homograft conduit: analysis of the long-term results. Thorac Cardiovasc Surg 1980, 28:21-25.
117. Nudel D., Berman N., Talner N. Effects of acutely increasing systemic vascular resistance on arterial oxygen tension in tetralogy of Fallot. Pediatrics 1976, 58:248.
118. Borrow K.M., Green L.H., Castenda A.R. Left ventricular function after repair of tetralogy of Fallot and its relationship to age at surgery. Circulation 1980, 61:1150.
119. Reduto L.A., Berger H.J., Johnstone D.E., et al. Radionuclide assessment of right and left ventricular exercise reserve after total correction of tetralogy of Fallot. Am J Cardiol 1980, 45:1013-1018.
120. Bove E.L., Byrum C.J., Thomas F.D. The influence of pulmonary insufficiency on ventricular function following repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 1983, 85:691.
121. Lang P., Chipman C.W., Siden H. Early assessment of hemodynamic status after 24 hours (intensive care unit) and one year postoperative data in 98 patients. Am J Cardiol 1982, 49:1733.
122. Nollert G., Fischlein T., Bouterwek S., et al. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol 1997, 30:1374-1383.
123. Carvalho J.S., Shinebourne E.A., Busst C., et al. Exercise capacity after complete repair of tetralogy of Fallot: deleterious effects of residual pulmonary regurgitation. Br Heart J 1992, 67:470-473.
124. Gatzoulis M.A., Balaji S., Webber S.A., et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000, 356:975-981.
125. Marie P.Y., Marcon F., Brunotte F., et al. Right ventricular overload and induced sustained ventricular tachycardia in operatively "repaired" tetralogy of Fallot. Am J Cardiol 1992, 69:785-789.
126. Hanley F.L., Sade R.M., Blackstone E.H., et al. Outcomes in neonatal pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg 1993, 105:406-427.
127. Giglia T.M., Mandell V.S., Connor A.R., et al. Diagnosis and management of right ventricle-dependent coronary circulation in pulmonary atresia with intact ventricular septum. Circulation 1992, 86:1516-1528.
128. Silver M.M., Pollock J., Silver M.D., et al. Calcification in porcine xenograft valves in children. Am J Cardiol 1980, 45:685-689.
129. Heck H.A., Schieken R.M., Lauer R.M., et al. Conduit repair for complex congenital heart disease. J Thorac Cardiovasc Surg 1978, 75:806.
130. Brown J.W., Ruzmetov M., Rodefeld M.D., et al. Valved bovine jugular vein conduits for right ventricular outflow tract reconstruction in children: an attractive alternative to pulmonary homograft. Ann Thorac Surg 2006, 82:909-916.
131. Fiore A.C., Ruzmetov M., Huynh D., et al. Comparison of bovine jugular vein with pulmonary homograft conduits in children less than 2 years of age. Eur J Cardiothorac Surg 2010.
132. Otero Coto E., Norwood W.I. Lang P: Modified Senning operation for treatment of transposition of the great arteries. J Thorac Cardiovasc Surg 1979, 78:721.
133. Senning A. Surgical correction of transposition of the great vessels. Surgery 1966, 59:334-336.
134. Hagler D.J., Ritter D.G., Mair D.D. Clinical, angiographic and hemodynamic assessment of late results after Mustard operation. Circulation 1978, 57:1214.
135. Jatene A.D., Fontes V.F., Souza L.C.B. Anatomic correction of transposition of the great arteries. J Thorac Cardiovasc Surg 1982, 83:20.
136. Castaneda A.R., Norwood W.I., Jonas R.A. Transposition of the great arteries and intact ventricular septum: anatomical repair in the neonate. Ann Thorac Surg 1984, 38:438.
137. Di Dontato R.M., Fujii A.M., Jonas R.A., et al. Age-dependent ventricular response to pressure overload. Considerations for the arterial switch operation. J Thorac Cardiovasc Surg 1992, 104:713-722.
138. Wernovsky G, Giglia TM, Jonas RA, et al: Course in the intensive care unit after "preparatory" pulmonary artery banding and aortopulmonary shunt placement for transposition of the great arteries with low left ventricular pressure, Circulation 86(5 Suppl): II133-II139, 1992.
139. Wernovsky G., Mayer J.E., Jonas R.A., et al. Factors influencing early and late outcome of the arterial switch operation for transposition of the great arteries. J Thorac Cardiovasc Surg 1995, 109:289-301.
140. Wernovsky G., Sanders S.P. Coronary artery anatomy and transposition of the great arteries. Coron Artery Dis 1993, 4:148-157.
141. Day R.W., Laks H., Drinkwater D.C. The influence of coronary anatomy on the arterial switch operation in neonates. J Thorac Cardiovasc Surg 1992, 104:706-712.
142. Rastelli G.C., McGoon D.C., Wallace R.B. Anatomic correction of transposition of the great arteries with ventricular septal defect and subpulmonary stenosis. J Thorac Cardiovasc Surg 1969, 58:545-552.
143. Merlo M., de Tommasi S.M., Brunelli F., et al. Long-term results after atrial correction of complete transposition of the great arteries. Ann Thorac Surg 1991, 51:227-231.
144. Helbing W.A., Hansen B., Ottenkamp J., et al. Long-term results of atrial correction for transposition of the great arteries. Comparison of Mustard and Senning operations. J Thorac Cardiovasc Surg 1994, 108:363-372.
145. Benson L.N., Bonet J., McLaughlin P. Assessment of right ventricular function during supine bicycle exercise after Mustard's operation. Circulation 1982, 65:1052.
146. Gelatt M., Hamilton R.M., McCrindle B.W., et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol 1997, 29:194-201.
147. Ramsay J.M., Venables A.W., Kelly M.J., et al. Right and left ventricular function at rest and with exercise after the Mustard operation for transposition of the great arteries. Br Heart J 1984, 51:364-370.
148. Tanel R.E., Wernovsky G., Landzberg M.J., et al. Coronary artery abnormalities detected at cardiac catheterization following the arterial switch operation for transposition of the great arteries. Am J Cardiol 1995, 76:153-157.
149. Massin M., Hovels-Gurich H., Dabritz S., et al. Results of the Bruce treadmill test in children after arterial switch operation for simple transposition of the great arteries. Am J Cardiol 1998, 81:56-60.
150. Jenkins K.J., Hanley F.L., Colan S.D., et al. Function of the anatomic pulmonary valve in the systemic circulation. Circulation 1991, 84:III173-III179.
151. Rhodes L.A., Wernovsky G., Keane J.F., et al. Arrhythmias and intracardiac conduction after the arterial switch operation. J Thorac Cardiovasc Surg 1995, 109:303-310.
152. Colan S.D., Boutin C., Castaneda A.R., et al. Status of the left ventricle after arterial switch operation for transposition of the great arteries. Hemodynamic and echocardiographic evaluation. J Thorac Cardiovasc Surg 1995, 109:311-321.
153. Adatia I., Atz A.M., Jonas R.A., et al. Diagnostic use of inhaled nitric oxide after neonatal cardiac operations. J Thorac Cardiovasc Surg 1996, 112:1403-1405.
154. Raisher B.D., Grant J.W., Martin T.C., et al. Complete repair of total anomalous pulmonary venous connection in infancy. J Thorac Cardiovasc Surg 1992, 104:443-448.
155. Jenkins K.J., Sanders S.P., Orav E.J., et al. Individual pulmonary vein seize and survival in infants with totally anomalous pulmonary venous connection. J Am Coll Cardiol 1993, 22:201-206.
156. Haworth S.G. Pulmonary vascular disease in secundum atrial septal defect in childhood. Am J Cardiol 1983, 51:265.
157. Collins G. Ventricular septal defect: clinical and hemodynamic changes in the first five years of life. Am Heart J 1972, 84:695.
158. Rabinovitch M., Haworth S.G., Castaneda A.R., et al. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation 1978, 58:1107-1122.
159. Friedman W.F., Heiferman M.F. Clinical problems of postoperative pulmonary vascular disease. Am J Cardiol 1982, 50:631-636.
160. Haworth S.G., Sauer U., Buhlmeyer K., et al. Development of the pulmonary circulation in ventricular septal defect: a quantitative structural study. Am J Cardiol 1977, 40:781-788.
161. Vincent R.N., Lang P., Elixson E.M., et al. Measurement of extravascular lung water in infants and children after cardiac surgery. Am J Cardiol 1984, 54:161-165.
162. Cordell D., Graham T.P., Atwood G.F. Left heart volume characteristics following ventricular septal closure defects in infancy. Circulation 1976, 54:417.
163. Jablonsky G., Hilton J.D., Liu P. Rest and exercise ventricular function in adults with congenital ventricular septal defects. Am J Cardiol 1983, 51:293.
164. Studer M., Blackstone E.H., Kirklin J.W., et al. Determinants of early and late results of repair of atrioventricular septal (canal) defects. J Thorac Cardiovasc Surg 1982, 84:523-542.
165. Rizzoli G., Mazzucco A., Maizza F., et al. Does Down syndrome affect prognosis of surgically managed atrioventricular canal defects?. J Thorac Cardiovasc Surg 1992, 104:945-953.
166. Spach M.S., Serwer G.A., Anderson P.A., et al. Pulsatile aortopulmonary pressure-flow dynamics of patent ductus arteriosus in patients with various hemodynamic states. Circulation 1980, 61:110-122.
167. Bancalari E., Jesse M.J., Gelband H., et al. Lung mechanics in congenital heart disease with increased and decreased pulmonary blood flow. J Pediatr 1977, 90:192.
168. Gerhardt T., Bancalari E. Lung compliance in newborns with patent ductus arteriosus before and after surgical ligation. Biol Neonate 1980, 38:96.
169. Mahony L., Carnero V., Brett C. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med 1982, 306:506.
170. Rashkind W.J., Mullins C.E., Hellenbrand W.E., et al. Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System. Circulation 1987, 75:583-592.
171. Laborde F., Noirhomme P., Karam J., et al. A new video-assisted thorascopic surgical technique for interruption of patent ductus arteriosus in infants and children. J Thorac Cardiovasc Surg 1993, 105:278-280.
172. Burke R.P., Wernovsky G., van der Velde M., et al. Video-assisted thoracoscopic surgery for congenital heart disease. J Thorac Cardiovasc Surg 1995, 109:499-507.
173. Robinson S., Gregory G.A. Fentanyl-air-oxygen anesthesia for ligation of patent ductus arteriosus in preterm infants. Anesth Analg 1981, 60:331-334.
174. Zbar R.I., Chen A.H., Behrendt D.M., et al. Incidence of vocal fold paralysis in infants undergoing ligation of patent ductus arteriosus. Ann Thorac Surg 1996, 61:814-816.
175. Fan L.L., Campbell D.N., Clarke D.R., et al. Paralyzed left vocal cord associated with ligation of patent ductus arteriosus. J Thorac Cardiovasc Surg 1989, 98:611-613.
176. Odegard K.C., Kirse D.J., Del Nido P.J., et al. Intraoperative recurrent laryngeal nerve monitoring during video-assisted thoracoscopic surgery for patent ductus arteriosus. J Cardiothorac Vasc Anesth 2000, 14:562-564.
177. Baylen B., Meyer R.A., Korfhagen J. Left ventricular performance in the critically ill premature infant with patent ductus arteriosus and pulmonary disease. Circulation 1977, 55:182.
178. Marcelletti C., McGood D.C., Mair D.D. The natural history of truncus arteriosus. Circulation 1976, 54:108.
179. Bove E.L., Lupinetti F.M., Pridjian A.K., et al. Results of a policy of primary repair of truncus arteriosus in the neonate. J Thorac Cardiovasc Surg 1993, 105:1057-1066.
180. Ebert P.A., Robinson S.J., Stanger P. Pulmonary artery conduits in infants younger than six months of age. J Thorac Cardiovasc Surg 1976, 72:351.
181. Roth S., Keane J.F. Balloon aortic valvuloplasty. Prog Pediatr Cardiol 1992, 3-16.
182. Anyanwu E., Klemm C., Achatzy R., et al. Surgery of coarctation of the aorta: a nine-year review of 253 patients. Thorac Cardiovasc Surg 1984, 32:350-357.
183. McCrindle B.W., Jones T.K., Morrow W.R., et al. Acute results of balloon angioplasty of native coarctation versus recurrent aortic obstruction are equivalent. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators. J Am Coll Cardiol 1996, 28:1810-1817.
184. Rao P.S., Thapar M.K., Galal O., et al. Follow-up results of balloon angioplasty of native coarctation in neonates and infants. Am Heart J 1990, 120:1310-1314.
185. Ashburn D.A., McCrindle B.W., Tchervenkov C.I., et al. Outcomes after the Norwood operation in neonates with critical aortic stenosis or aortic valve atresia. J Thorac Cardiovasc Surg 2003, 125:1070-1082.
186. Kumar R.K., Newburger J.W., Gauvreau K., et al. Comparison of outcome
187. Iannettoni M.D., Bove E.L., Mosca R.S., et al. Improving results with first-stage palliation for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 1994, 107:934-940.
188. Donner R. Hypoplastic left heart syndrome. Curr Treat Options Cardiovasc Med 2000, 2:469-480.
189. Mahle W.T., Spray T.L., Wernovsky G., et al. Survival after reconstructive surgery for hypoplastic left heart syndrome: a 15-year experience from a single institution. Circulation 2000, 102(19 suppl 3):III136-III141.
190. Mosca R.S., Kulik T.J., Goldberg C.S., et al. Early results of the Fontan procedure in one hundred consecutive patients with hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 2000, 119:1110-1118.
191. Norwood W.I., Lang P., Hansen D.D. Physiologic repair of aortic atresia-hypoplastic left heart syndrome. N Engl J Med 1983, 308:23.
192. Daebritz S.H., Nollert G.D., Zurakowski D., et al. Results of Norwood stage I operation: comparison of hypoplastic left heart syndrome with other malformations. J Thorac Cardiovasc Surg 2000, 119:358-367.
193. Hoffman G.M., Tweddell J.S., Ghanayem N.S., et al. Alteration of the critical arteriovenous oxygen saturation relationship by sustained afterload reduction after the Norwood procedure. J Thorac Cardiovasc Surg 2004, 127:738-745.
194. Mosca R.S., Bove E.L., Crowley D.C., et al. Hemodynamic characteristics of neonates following first stage palliation for hypoplastic left heart syndrome. Circulation 1995, 92(suppl II):II-267-II-271.
195. Riordan C., Randsbaek F., Storey J. Balancing pulmonary and systemic arterial flows in parallel circulations: the value of monitoring systemic venous oxygen saturations. Cardiol Young 1997, 7:74-79.
196. Maher K.O., Pizarro C., Gidding S.S., et al. Hemodynamic profile after the Norwood procedure with right ventricle to pulmonary artery conduit. Circulation 2003, 108:782-784.
197. Sano S., Ishino K., Kawada M., et al. Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. Semin Thorac Cardiovasc Surg Pediatr Card Surg Ann 2004, 7:22-31.
198. Sano S., Ishino K., Kawada M., et al. Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 2003, 126:504-509.
199. Ohye R.G., Sleeper L.A., Mahony L., et al. Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med 2010, 362:1980-1992.
200. Bailey L.L., Gundry S.R., Razzouk A.J., et al. Bless the babies: one hundred fifteen late survivors of heart transplantation during the first year of life. J Thorac Cardiovasc Surg 1993, 105:805-815.
201. Armitage J.M., Fricker F.J., del Nido P., et al. A decade (1982 to 1992) of pediatric cardiac transplantation and the impact of FK 506 immunosuppression. J Thorac Cardiovasc Surg 1993, 105:464-473.
202. Starnes V.A., Griffin M.L., Pitlick P.T., et al. Current approach to hypoplastic left heart syndrome. Palliation, transplantation, or both?. J Thorac Cardiovasc Surg 1992, 104:189-194.
203. Freedom R.M. Neurodevelopmental outcome after the fontan procedure in children with the hypoplastic left heart syndrome and other forms of single ventricle pathology: challenges unresolved. J Pediatr 2000, 137:602-604.
204. Wernovsky G., Stiles K.M., Gauvreau K., et al. Cognitive development after the Fontan operation. Circulation 2000, 102:883-889.
205. Galantowicz M., Cheatham J.P. Lessons learned from the development of a new hybrid strategy for the management of hypoplastic left heart syndrome. Pediatr Cardiol 2005, 26:190-199.
206. Barron D.J., Kilby M.D., Davies B. Hypoplastic left heart syndrome. Lancet 2009, 374:551-564.
207. Akinturk H., Michel-Behnke I., Valeske K., et al. Hybrid transcatheter-surgical palliation: basis for univentricular or biventricular repair: the Giessen experience. Pediatr Cardiol 2007, 28:79-87.
208. Pizarro C., Derby C.D., Baffa J.M. Improving the outcome of high risk neonates with hypoplastic left heart syndrome: hybrid procedure or conventional surgical palliation?. Eur J Cardiothorac Surg 2008, 33:613-618.
209. Pizarro C., Murdison K.A., Derby C.D., Radtke W. Stage II reconstruction after hybrid palliation for high-risk patients with a single ventricle. Ann Thorac Surg 2008, 85:1382-1388.
210. Galantowicz M., Cheatham J.P., Phillips A., et al. Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve, Ann Thorac Surg 2008, 85:2063-2070.
211. Bacha E.A., Daves S., Hardin J., et al. Single-ventricle palliation for high-risk neonates: the emergence of an alternative hybrid stage I strategy. J Thorac Cardiovasc Surg 2006, 131:163-168.